March 10 (Reuters) - Corcept Therapeutics Inc CORT.O:
CORCEPT THERAPEUTICS INITIATES MOMENTUM TRIAL TO DETERMINE PREVALENCE OF HYPERCORTISOLISM IN PATIENTS WITH RESISTANT HYPERTENSION
Source text: nBw9cq9NLa
Further company coverage: CORT.O
((Reuters.Briefs@thomsonreuters.com;))